Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer

R (Rosa) Hoekstra, FYFL de Vos, Ferry Eskens, JA Gietema, Ate van der Gaast, HJM Groen, RA Knight, RA Carr, RA Humerickhouse, Jaap Verweij, EGE de Vries

Research output: Contribution to journalArticleAcademicpeer-review

86 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)5188-5197
Number of pages10
JournalJapanese Journal of Clinical Oncology
Volume23
Issue number22
Publication statusPublished - 2005

Cite this